Marco J.D. Tangelder

Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B

Wolfgang Miesbach, Karina Meijer, Michiel Coppens et al. · Blood · 2017 · 301 citations · Full text

Life Sciences, Genetics, Molecular Biology +14

Cardioprotective Medication Is Associated With Improved Survival in Patients With Peripheral Arterial Disease

Harm H.H. Feringa, Virginie H. van Waning, Jeroen J. Bax et al. · Journal of the American College of Cardiology · 2006 · 169 citations

Medicine, Cardiology, Pharmacology +14

Growth predictors and prognosis of small abdominal aortic aneurysms

Felix J.V. Schlösser, Marco J.D. Tangelder, Hence J.M. Verhagen et al. · Journal of Vascular Surgery · 2008 · 148 citations · Full text

Medicine, Surgery, Cardiothoracic Surgery +10

The Long-term Prognostic Value of the Resting and Postexercise Ankle-Brachial Index

Harm H.H. Feringa, Jeroen J. Bax, Virginie H. van Waning et al. · Archives of Internal Medicine · 2006 · 141 citations · Full text

Medicine, Internal Medicine, Sports Medicine +13

Therapeutic hFIX Activity Achieved after Single AAV5-hFIX Treatment in Hemophilia B Patients and NHPs with Pre-existing Anti-AAV5 NABs

Anna Majowicz, Bart Nijmeijer, Margit H. Lampen et al. · Molecular Therapy — Methods & Clinical Development · 2019 · 125 citations · Full text

Medicine, Hematology, Molecular Medicine +13